Active Ingredient(s): Verteporfin
FDA Approved: * April 12, 2000
Pharm Company: * QLT
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Visudyne Overview

Verteporfin (trade name Visudyne), a benzoporphyrin derivative, is a medication used as a photosensitizer for photodynamic therapy to eliminate the abnormal blood vessels in the eye associated with conditions such as the wet form of macular degeneration. Verteporfin accumulates in these abnormal blood vessels and, when stimulated by nonthermal red light with a wavelength of 689nm[1] in the presence of oxygen, produces highly reactive short-lived singlet oxygen and other reacti...

Read more Visudyne Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Visudyne Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 15mg, 15mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Visudyne: (2 results)

Sorted by National Drug Code
  • 0187-5600 Visudyne 15 mg/1 Intravenous Injection, Powder, Lyophilized, for Solution by Valeant Pharmaceuticals North America LLC
  • 50236-001 Visudyne 15 mg/1 Intravenous Injection, Powder, Lyophilized, for Solution by Qlt Ophthalmics, Inc.

Other drugs which contain Verteporfin or a similar ingredient: (1 result)